CA3134705A1 - Method of introducing target-specific foreign gene - Google Patents
Method of introducing target-specific foreign gene Download PDFInfo
- Publication number
- CA3134705A1 CA3134705A1 CA3134705A CA3134705A CA3134705A1 CA 3134705 A1 CA3134705 A1 CA 3134705A1 CA 3134705 A CA3134705 A CA 3134705A CA 3134705 A CA3134705 A CA 3134705A CA 3134705 A1 CA3134705 A1 CA 3134705A1
- Authority
- CA
- Canada
- Prior art keywords
- exogenous dna
- dna
- polypeptide
- gene
- cho cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019070329 | 2019-04-02 | ||
| JP2019-070329 | 2019-04-02 | ||
| PCT/JP2020/014980 WO2020204055A1 (ja) | 2019-04-02 | 2020-04-01 | 標的特異的な外来遺伝子の導入方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3134705A1 true CA3134705A1 (en) | 2020-10-08 |
Family
ID=72668649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3134705A Pending CA3134705A1 (en) | 2019-04-02 | 2020-04-01 | Method of introducing target-specific foreign gene |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12344859B2 (https=) |
| EP (1) | EP3950938A4 (https=) |
| JP (1) | JP7522100B2 (https=) |
| KR (1) | KR102655024B1 (https=) |
| CN (1) | CN113661238B (https=) |
| AU (1) | AU2020252840B2 (https=) |
| CA (1) | CA3134705A1 (https=) |
| IL (1) | IL286630B2 (https=) |
| MX (1) | MX2021011903A (https=) |
| SG (1) | SG11202110076PA (https=) |
| TW (1) | TWI851703B (https=) |
| WO (1) | WO2020204055A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025216715A1 (en) * | 2024-04-12 | 2025-10-16 | Agency For Science, Technology And Research | Identification of transcriptional hotspots in cho cells |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707189B1 (fr) | 1993-07-09 | 1995-10-13 | Gradient Ass | Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé. |
| US6800457B2 (en) | 1998-09-22 | 2004-10-05 | Bristol-Myers Squibb Company | Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| US6521419B1 (en) * | 1998-09-22 | 2003-02-18 | Kanakaraju Koduri | Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| CN1182244C (zh) * | 1999-05-10 | 2004-12-29 | 中外制药株式会社 | 培养细胞的方法 |
| DE60140474D1 (de) | 2000-09-08 | 2009-12-24 | Univ Zuerich | Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten |
| CA2418835A1 (en) | 2000-10-16 | 2002-04-25 | Phylos, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| WO2005040229A2 (en) | 2003-10-24 | 2005-05-06 | Avidia, Inc. | Ldl receptor class a and egf domain monomers and multimers |
| CN1618955A (zh) * | 2003-11-20 | 2005-05-25 | 中国人民解放军军事医学科学院生物工程研究所 | 一种CHO/dhfr－细胞定点整合表达系统 |
| JP4818936B2 (ja) * | 2005-01-05 | 2011-11-16 | 中外製薬株式会社 | 細胞の培養方法およびその利用 |
| JP2007325571A (ja) | 2006-06-09 | 2007-12-20 | Toto Ltd | 組換え哺乳類動物細胞を用いたタンパク質生産方法 |
| CA2659574C (en) | 2006-08-02 | 2017-04-25 | The Uab Research Foundation | Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity |
| WO2008151219A1 (en) | 2007-06-04 | 2008-12-11 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| EP3176263A1 (en) | 2007-08-10 | 2017-06-07 | Toto Ltd. | Method of producing recombinant mammalian cells |
| US8252557B2 (en) * | 2008-10-28 | 2012-08-28 | Chugai Seiyaku Kabushiki Kaisha | Peptide-containing culture medium for culturing animal cell |
| JP2010210772A (ja) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
| US20130034875A1 (en) * | 2009-10-01 | 2013-02-07 | Toto Ltd. | Dna construct, and process for production of recombinant cho cell using same |
| AU2012240164A1 (en) | 2011-04-05 | 2013-11-14 | The Scripps Research Institute | Chromosomal landing pads and related uses |
| EP2711428A1 (en) | 2012-09-21 | 2014-03-26 | Lonza Biologics plc. | Site-specific integration |
| BR112015031639A2 (pt) | 2013-06-19 | 2019-09-03 | Sigma Aldrich Co Llc | integração alvo |
| WO2015092735A1 (en) * | 2013-12-20 | 2015-06-25 | Novartis Ag | Novel eukaryotic cells and methods for recombinantly expressing a product of interest |
| JP6858559B2 (ja) | 2014-08-20 | 2021-04-14 | 中外製薬株式会社 | 蛋白質溶液の粘度測定方法 |
| KR102243243B1 (ko) | 2014-10-23 | 2021-04-22 | 리제너론 파마슈티칼스 인코포레이티드 | 신규한 cho 통합 부위 및 이의 용도 |
| CN104818253B (zh) * | 2015-03-24 | 2018-03-09 | 成都贝爱特生物科技有限公司 | 靶向定点整合cho细胞系的改造及其用途 |
| DE102015222931A1 (de) * | 2015-11-20 | 2017-05-24 | Continental Teves Ag & Co. Ohg | Anordnung zur Messung eines durch Bremskraft erzeugten Verschiebeweges |
| EA201892137A1 (ru) | 2016-04-20 | 2019-03-29 | Регенерон Фармасьютикалз, Инк. | Композиции и способы получения антител, основанные на применении локусов, обеспечивающих повышенную экспрессию |
| US11512144B2 (en) | 2016-04-20 | 2022-11-29 | Regeneran Pharmaceuticals, Inc. | Compositions and methods for making antibodies based on use of an expression-enhancing loci |
| EP4130280A3 (en) | 2016-12-20 | 2023-04-19 | Development Center for Biotechnology | Targeted integration sites in chinese hamster ovary cell genome |
| SG11202000966XA (en) * | 2017-08-11 | 2020-02-27 | Boehringer Ingelheim Int | Integration sites in CHO cells |
-
2020
- 2020-04-01 KR KR1020217034905A patent/KR102655024B1/ko active Active
- 2020-04-01 JP JP2021512163A patent/JP7522100B2/ja active Active
- 2020-04-01 WO PCT/JP2020/014980 patent/WO2020204055A1/ja not_active Ceased
- 2020-04-01 AU AU2020252840A patent/AU2020252840B2/en active Active
- 2020-04-01 SG SG11202110076PA patent/SG11202110076PA/en unknown
- 2020-04-01 MX MX2021011903A patent/MX2021011903A/es unknown
- 2020-04-01 CN CN202080026711.XA patent/CN113661238B/zh active Active
- 2020-04-01 US US17/600,319 patent/US12344859B2/en active Active
- 2020-04-01 TW TW109111209A patent/TWI851703B/zh active
- 2020-04-01 CA CA3134705A patent/CA3134705A1/en active Pending
- 2020-04-01 EP EP20784329.3A patent/EP3950938A4/en active Pending
- 2020-04-01 IL IL286630A patent/IL286630B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113661238A (zh) | 2021-11-16 |
| EP3950938A4 (en) | 2023-01-18 |
| IL286630B2 (en) | 2025-05-01 |
| US20220170047A1 (en) | 2022-06-02 |
| BR112021018313A2 (pt) | 2021-11-23 |
| MX2021011903A (es) | 2021-10-26 |
| AU2020252840A1 (en) | 2021-11-04 |
| KR20210146362A (ko) | 2021-12-03 |
| CN113661238B (zh) | 2024-08-27 |
| IL286630A (en) | 2021-12-01 |
| TWI851703B (zh) | 2024-08-11 |
| US12344859B2 (en) | 2025-07-01 |
| SG11202110076PA (en) | 2021-10-28 |
| IL286630B1 (en) | 2025-01-01 |
| KR102655024B1 (ko) | 2024-04-04 |
| EP3950938A1 (en) | 2022-02-09 |
| JPWO2020204055A1 (https=) | 2020-10-08 |
| AU2020252840B2 (en) | 2025-01-23 |
| WO2020204055A1 (ja) | 2020-10-08 |
| JP7522100B2 (ja) | 2024-07-24 |
| TW202043478A (zh) | 2020-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5117542B2 (ja) | 組換え第ｖｉｉｉ因子を高発現させるためのｂｈｋ細胞 | |
| CN108368505B (zh) | 改善的flare(流式细胞术减弱报道蛋白表达)技术用于快速批量分选 | |
| CN112272704A (zh) | 改造的cascade组分和cascade复合体 | |
| JP2012070744A (ja) | 哺乳類βアクチンプロモーターを利用した発現系 | |
| US9365637B2 (en) | Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide | |
| JP2020022514A (ja) | 産生細胞株エンハンサー | |
| JP2019193659A (ja) | 発現カセット | |
| US12344859B2 (en) | Method of introducing target-specific foreign gene | |
| EP3159411B1 (en) | Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof | |
| HK40057590A (en) | Method of introducing target-specific foreign gene | |
| HK40057590B (zh) | 引入靶特异性外源基因的方法 | |
| KR101947869B1 (ko) | 차세대 시퀀싱 기반 재조합 단백질 발현을 위한 세포 내 핫스팟 영역 탐색 방법 | |
| BR112021018313B1 (pt) | Métodos para introdução de um dna exógeno codificando um polipeptídeo de interesse dentro de uma célula cho, e para produção de um polipeptídeo | |
| JP4958905B2 (ja) | ペプチド鎖発現を増大させるための物質および方法 | |
| CN120936717A (zh) | 用于基因表达构建体的间隔区 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220812 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250226 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250324 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250324 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250324 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250530 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250603 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250724 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250724 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260324 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260324 |